
-
Fleeing Pakistan, Afghans rebuild from nothing
-
US Supreme Court to hear case against LGBTQ books in schools
-
Pistons snap NBA playoff skid, vintage Leonard leads Clippers
-
Migrants mourn pope who fought for their rights
-
Duplantis kicks off Diamond League amid Johnson-led changing landscape
-
Taliban change tune towards Afghan heritage sites
-
Kosovo's 'hidden Catholics' baptised as Pope Francis mourned
-
Global warming is a security threat and armies must adapt: experts
-
Can Europe's richest family turn Paris into a city of football rivals?
-
Climate campaigners praise a cool pope
-
As world mourns, cardinals prepare pope's funeral
-
US to impose new duties on solar imports from Southeast Asia
-
Draft NZ law seeks 'biological' definition of man, woman
-
Auto Shanghai to showcase electric competition at sector's new frontier
-
Tentative tree planting 'decades overdue' in sweltering Athens
-
Indonesia food plan risks 'world's largest' deforestation
-
Gold hits record, stocks slip as Trump fuels Fed fears
-
Trump helps enflame anti-LGBTQ feeling from Hungary to Romania
-
Woe is the pinata, a casualty of Trump trade war
-
Trump tariffs torch chances of meeting with China's Xi
-
X rival Bluesky adds blue checks for trusted accounts
-
China to launch new crewed mission into space this week
-
Morocco volunteers on Sahara clean-up mission
-
Latin America fondly farewells its first pontiff
-
'I wanted it to work': Ukrainians disappointed by Easter truce
-
Harvard sues Trump over US federal funding cuts
-
'One isn't born a saint': School nuns remember Pope Francis as a boy
-
'I don't miss tennis' says Nadal
-
Biles 'not so sure' about competing at Los Angeles Olympics
-
Gang-ravaged Haiti nearing 'point of no return', UN warns
-
US assets slump again as Trump sharpens attack on Fed chief
-
Forest see off Spurs to boost Champions League hopes
-
Oscar voters required to view all films before casting ballots
-
Bucks' Lillard upgraded to 'questionable' for game 2 v Pacers
-
Duplantis and Biles win Laureus World Sports Awards
-
US urges curb of Google's search dominance as AI looms
-
The Pope with 'two left feet' who loved the 'beautiful game'
-
With Pope Francis death, Trump loses top moral critic
-
Mourning Americans contrast Trump approach to late Pope Francis
-
Leeds and Burnley promoted to Premier League
-
Racist gunman jailed for life over US supermarket massacre
-
Macron vows to step up reconstruction in cyclone-hit Mayotte
-
Gill, Sudharsan help toppers Gujarat boss Kolkata in IPL
-
Messi, San Lorenzo bid farewell to football fan Pope Francis
-
Leeds on brink of Premier League promotion after smashing Stoke
-
In Lourdes, Catholic pilgrims mourn the 'pope of the poor'
-
Korir wins men's Boston Marathon, Lokedi upstages Obiri
-
China's CATL launches new EV sodium battery
-
Korir wins Boston Marathon, Lokedi upstages Obiri
-
Francis, a pope for the internet age

Chinese medical portal censored after doubting herbal 'Covid remedy'
A popular Chinese medical information site has been censored by authorities for "violation of relevant laws and regulations", months after its criticism of a government-backed herbal Covid-19 treatment sent shares in a pharmaceutical giant tumbling.
DXY, which counts tech giant Tencent among its investors and runs a host of health-related services, previously questioned the value of Lianhua Qingwen, a herbal remedy marketed for fever and sore throats, as a Covid-19 treatment.
China approved the concoction -- made up of ingredients like honeysuckle and apricot seeds -- as a Covid-19 treatment in 2020, and it was distributed to Shanghai residents during the city's outbreak this year.
DXY's article was part of a wave of reports that caused shares in Lianhua Qingwen's producer -- one of China's largest traditional medicine companies -- to plunge.
The website has now been banned from posting on at least five of its Weibo social media accounts, with a notice at the top of its official page saying that due to "violation of relevant laws and regulations, this user is currently prohibited from posting".
DXY's official WeChat accounts, which typically publish multiple articles a day on medical topics, have not been updated since Monday.
The Weibo notice did not specify which regulations had been violated by DXY, which did not immediately respond to AFP's request for comment.
The Chinese government has increasingly promoted traditional medicine at home and abroad in recent years, often with nationalistic undertones.
DXY's coverage prompted criticism that it was targeting traditional Chinese medicine (TCM) in order to promote Western pharmaceuticals.
The United States and other countries have warned there is no evidence Lianhua Qingwen works to prevent or cure Covid-19, even as it has increasingly been promoted by government authorities in China and Hong Kong.
The US Food and Drug Administration has said it has not approved Lianhua Qingwen and that coronavirus-related claims about it were "not supported by competent and reliable scientific evidence".
Beijing issued its first white paper on TCM in 2016, laying out plans to build medicine centres and dispatch practitioners to developing countries in Africa and Southeast Asia.
President Xi Jinping has described TCM as a "treasure of Chinese civilisation" and has said that it should be given as much weight as other treatments.
Beijing's National Health Commission has also dispatched TCM practitioners as part of its medical reinforcement teams sent to fight Covid-19 outbreaks across the country.
G.Teles--PC